Theravance Biopharma Inc TBPH:NASDAQ

RT Quote | NASDAQ | USD
Last | 06/22/21 EDT
17.45quote price arrow down-0.11 (-0.63%)
Volume
503,900
52 week range
14.48 - 22.99

...

Loading . . .
  • Open17.49
  • Day High17.61
  • Day Low17.26
  • Prev Close17.45
  • 52 Week High22.99
  • 52 Week High Date06/23/20
  • 52 Week Low14.48
  • 52 Week Low Date10/01/20

Key Stats

  • Market Cap1.139B
  • Shares Out65.28M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta0.90
  • YTD % Change-1.8

KEY STATS

  • Open17.49
  • Day High17.61
  • Day Low17.26
  • Prev Close17.45
  • 52 Week High22.99
  • 52 Week High Date06/23/20
  • 52 Week Low14.48
  • 52 Week Low Date10/01/20
  • Market Cap1.139B
  • Shares Out65.28M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta0.90
  • YTD % Change-1.8

RATIOS/PROFITABILITY

  • EPS (TTM)-4.32
  • P/E (TTM)-4.04
  • Fwd P/E (NTM)-6.29
  • EBITDA (MRQ)-303.26M
  • ROE (MRQ)-677.87%
  • Revenue (MRQ)66.25M
  • Gross Margin (MRQ)28.27%
  • Net Margin (MRQ)-414.54%
  • Debt To Equity (MRQ)-164.53%

EVENTS

  • Earnings Date08/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Theravance Biopharma Inc

There is no recent news for this security.

Profile

MORE
Theravance Biopharma, Inc. is a biopharmaceutical company. The Company is engaged in creating medicines for patients suffering from serious illness. The Company operates in the segment of discovery (research), development and commercialization of human therapeutics. The Company's pipeline of internally discovered product candidates includes medicines to address the unmet needs of patients being treated for serious conditions primarily in the acute care setting. Its commercial...
Rick Winningham
Chairman
Andrew Hindman
Chief Financial Officer
Bradford Shafer Esq., J.D.
Executive Vice President
Address
UGLAND HOUSE, SOUTH CHURCH STREET
George Town
KY1-1104
Cayman Islands

Top Peers

SYMBOLLASTCHG%CHG
MNKD
MannKind Corp
4.46-0.06-1.33%
AGEN
Agenus Inc
5.18-0.12-2.26%
PSNL
Personalis Inc
25.67+0.22+0.86%
CCXI
ChemoCentryx Inc
12.89-0.17-1.30%
GTHX
G1 Therapeutics Inc
21.36-0.17-0.79%